
(Sai-Parn) #WhiteMKT : Sufficient & Happy with every breath in and out.
Thailand
Joined July 2009
- Tweets145K
- Following665
- Followers19.6K
- Likes792
Thanaboramat, Touch retweeted
As the therapeutic benefits of GLP-1 medicines expand, the interest in the weight loss independent contributions continues to unfold linkinghub.elsevier.com/retr…
Thanaboramat, Touch retweeted
🇮🇩 A very close-up shot captures the terrifying moment a volcano erupts in Indonesia.
Nature at its most destructive.
Readers added context they thought people might want to know
The video does not show a real eruption; recent Indonesian activity (e.g. Anak Krakatau) produced ash plumes and small distant lava fountains observed from sea/monitoring posts, not this residential scene.
magma.esdm.go.id
cnbcindonesia.com/tech/202609071…
commons.wikimedia.org/wiki/File:Moun…
en.antaranews.com/news/430292/in…
Thanaboramat, Touch retweeted
Spain just went dark in the middle of the day.
Total solar eclipse. Absolutely unreal. 🌑🇪🇸
Tarragona, Spain 🇪🇸
Thanaboramat, Touch retweeted
Facebook ล่ม! ใช้งานบน PC ไม่ได้ แต่ มือถือยังใช้ได้ปกติ tnnthailand.com/socialtalk/2…
#Facebookล่ม #Facebook #TNN #TNNThailand #TNNช่อง16 #TNNONLINE
Thanaboramat, Touch retweeted
Can One Peptide Reduce Visceral Fat and Promote Longevity? 🧵
1/5) Tesamorelin is a peptide shown in randomized controlled human trials to reduce visceral fat by ~20%.
But that may be one of its least interesting effects.
Stick around to the end for the big reveal…
Thanaboramat, Touch retweeted
Canva is reportedly down for some users at the moment. Are you one of them? #Canva #CanvaDown
community.designtaxi.com/top…
Thanaboramat, Touch retweeted
🟥 NotebookLM ahora puede transformar Artículos, PDFs y Videos de YouTube en Ideas Estructuradas como si tuvieras un investigador del MIT trabajando contigo.
🔴 Aquí tienes los 10 Prompts que cambiarán la forma en que analizas información ⬇️
Thanaboramat, Touch retweeted
คุณ DANNY เจ้าของ Fitwhey นำอกไก่ปั่นเจ้าดังไปตรวจค่าโปรตีนและน้ำตาล ปรากฏว่าตกฉลากกันหมดยกเว้นแบรนด์เดียว
แต่ที่น่าตกใจเลยคือแบรนด์ดัง ที่ราคาแพงที่สุดโปรตีนต่างจากที่แจ้งไว้เยอะ และค่าน้ำตาลคือเหมือนกินชานมไข่มุก มันน่าโมโหจริงป่ะ? นี่คือเอาเปรียบผู้บริโภคอย่างแรงเลย
Thanaboramat, Touch retweeted
Claude is down, checked on downdetector too:
downdetector.in/en/status/cl…
#claudedown #cluadeoutage #outage
Thanaboramat, Touch retweeted
Claude AI is reportedly down for some users right now. Are you one of them? #ClaudeDown #Anthropic #ClaudeAiDown
community.designtaxi.com/top…
Replying to @satvik_93
ค่อนข้างคาดไม่ถึงแต่ยิ่งใหญ่ถ้าเป็นจริง การแก้ไขยีนที่มุ่งตรงไปยังบริเวณที่ไม่มีการเข้ารหัสของ LDLR สามารถให้ผลการควบคุม LDLR ที่ทำงานได้ ซึ่งให้ผลการลดที่ลึกไม่เพียงแต่ LDL-C และ ApoB แต่ยังรวมถึง Lp(a)
128
Thanaboramat, Touch retweeted
Somewhat unexpected but big if true; gene editing directed to non-coding regions of LDLR can yield functional LDLR upregulation, yielding deep reductions of not only LDL-C and ApoB but also Lp(a)
Thanaboramat, Touch retweeted
🫀 Lowering LDL-cholesterol is a cornerstone of CAD prevention—
…but is it enough?
This study explores a crucial gap:
👉 Why does significant coronary risk persist even at low LDL levels?
✨ Study at a glance (HURRICANE study):
🔹 479 patients with chronic coronary syndromes (CCS)
🔹 Comprehensive CCTA + metabolic profiling
🔹 CAD severity assessed by:
✔ CAD-RADS 2.0
✔ Leiden score
✨ Key findings:
⚠️ Paradoxical observation:
👉 Patients with LOW LDL (<70 mg/dL)
➡️ had MORE severe and extensive CAD
📊 As shown in the graphical abstract (page 2):
➡️ high CAD risk clusters with high fasting glucose, not LDL
🧠 The real driver: cardiometabolic risk
🔹 Metabolic syndrome (31%)
🔹 Pre-diabetes (26%)
🔹 Diabetes (21%)
👉 Strong independent predictors of CAD severity
📈 Risk impact:
✔ Metabolic syndrome → OR ~2.1
✔ Pre-diabetes → OR ~1.9
✔ Diabetes → OR ~6.1
📊 Key mechanistic insight:
👉 Dysregulation of glucose metabolism
➡️ emerges as the main contributor to residual atherosclerotic risk
✔ Insulin resistance
✔ Inflammation
✔ Atherogenic dyslipidaemia
⚠️ Critical clinical implication:
👉 LDL-focused strategies alone are not sufficient
➡️ Patients with low LDL may still have:
higher plaque burden
more non-calcified plaques
higher overall CAD risk
🧬 Imaging + metabolism = the future
👉 CCTA reveals:
✔ plaque burden
✔ plaque composition
✔ disease extent
👉 Combined with metabolic profiling →
➡️ more accurate risk stratification
💡 Clinical take-home message:
👉 In CCS patients:
✔ always assess cardiometabolic profile
✔ look beyond LDL
👉 Focus on:
glucose metabolism
insulin resistance
metabolic syndrome
🚨 Bottom line:
Residual coronary risk is driven less by LDL—and more by cardiometabolic dysfunction, especially glucose dysregulation.
#Cardiology #CCTA #CoronaryArteryDisease #LDL #Diabetes #MetabolicSyndrome #Cardiometabolic #PrecisionMedicine #CardiacImaging 🫀📊



























